Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony D'Urzo

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Therapeutics and Clinical Risk Management|August 31, 2013
Role of once-daily glycopyrronium bromide (NVA237) in the management of COPDAnthony D'Urzo
Expert Opinion on Pharmacotherapy|October 25, 2007
Mometasone furoate dry-powder inhaler for the control of persistent asthmaAnthony D'Urzo
Canadian Family Physician Medecin De Famille Canadien|September 17, 2002
Chronic cough. Three most common causesAnthony D'Urzo, Pieter Jugovic
Expert Review of Respiratory Medicine|July 14, 2012
Future of chronic obstructive pulmonary disease managementAnthony D'Urzo, Claus Vogelmeier
Pediatric Pulmonology|January 20, 2004
Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthmaBarry Zimmerman, Anthony D'Urzo, Denis Bérubé
NPJ Primary Care Respiratory Medicine|July 25, 2014
The challenge of objective confirmation of asthma diagnosis in primary careJatin Kaicker, Wilfred Dang, Anthony D'Urzo
NPJ Primary Care Respiratory Medicine|February 26, 2017
Use of concomitant inhaled corticosteroids: pooled data from two phase III studies of aclidinium plus formoterol in COPDAnthony D'Urzo, Dave Singh, Esther Garcia Gil
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 31, 2008
Inhaled mometasone furoate improves health-related quality of life in patients with persistent asthmaJill Karpel, Anthony D'urzo, Richard F Lockey
Respiratory Research|September 11, 2016
Pharmacological strategies to reduce exacerbation risk in COPD: a narrative reviewMarc Miravitlles, Anthony D'Urzo, Dave Singh, et al.
BMC Pulmonary Medicine|October 20, 2012
Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trialRobert A Nathan, Anthony D'Urzo, Viktor Blazhko, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Therapeutics and Clinical Risk Management|August 31, 2013
Role of once-daily glycopyrronium bromide (NVA237) in the management of COPDAnthony D'Urzo
Expert Opinion on Pharmacotherapy|October 25, 2007
Mometasone furoate dry-powder inhaler for the control of persistent asthmaAnthony D'Urzo
Canadian Family Physician Medecin De Famille Canadien|September 17, 2002
Chronic cough. Three most common causesAnthony D'Urzo, Pieter Jugovic
Expert Review of Respiratory Medicine|July 14, 2012
Future of chronic obstructive pulmonary disease managementAnthony D'Urzo, Claus Vogelmeier
Pediatric Pulmonology|January 20, 2004
Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthmaBarry Zimmerman, Anthony D'Urzo, Denis Bérubé
NPJ Primary Care Respiratory Medicine|July 25, 2014
The challenge of objective confirmation of asthma diagnosis in primary careJatin Kaicker, Wilfred Dang, Anthony D'Urzo
NPJ Primary Care Respiratory Medicine|February 26, 2017
Use of concomitant inhaled corticosteroids: pooled data from two phase III studies of aclidinium plus formoterol in COPDAnthony D'Urzo, Dave Singh, Esther Garcia Gil
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 31, 2008
Inhaled mometasone furoate improves health-related quality of life in patients with persistent asthmaJill Karpel, Anthony D'urzo, Richard F Lockey
Respiratory Research|September 11, 2016
Pharmacological strategies to reduce exacerbation risk in COPD: a narrative reviewMarc Miravitlles, Anthony D'Urzo, Dave Singh, et al.
BMC Pulmonary Medicine|October 20, 2012
Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trialRobert A Nathan, Anthony D'Urzo, Viktor Blazhko, et al.
Pageof 3